posterior uveitis

Cards (35)

  • uveal tissue
    • middle layer of the eye between sclera and retina
    • has ciliary body, iris, choroid and RPE
    • name derived from grape as looks like grape when dissected
    • each section has own function
    • contains complex immune cells as well as pigment containing melanocytes
    • classification of units - standardisation of uveitis nomenclature working group guidance, international study group, categorised based on anatomy, aetiology and time of clinical activity
  • positions of uveitis
    • classified according to primary sight of inflammation
    anterior
    • anterior chamber
    intermediate
    • vitreous and pars plana
    posterior
    • retina and choroid
    pan uveitis
    • entire uveal tract
  • causes of uveitis
    • infective - toxoplasmosis, TB and syphillus
    • non infectious - undifferentiated auto immune, reactive
    • masquerade - underlying disease such as malignancy
  • timing of uveitis
    • onset is sudden or insidious
    • duration - limited to 3 months or less or persistent
    • clinical course
    • acute - sudden onset and limited duration
    • recurrent - repeated episodes separate by inactive periods
    • chronic - persistent duration with relapse in less than 3 months
    • remission - no acitivity for more than 3 months
  • intermediate uveitis 

    • SUN classification
    • diagnosis is clinical 50% idiopathic, can be multiple sclerosis, sarcoidosis, Lyme disease, syphillis, TB
    • accounts for 15% of all uveitis
    • variable course
    • blurred vision, floaters, normally painless, no redness
    • VA dependent on severity and presence of CMO
    • have spill over inflammation in anteiror chamber, vitreous cells, haze and condensation
    • snow balls - white focal collections of inflammatory cells and exudates
    • snow banking - peripheral fibrovascular plaque
    • peripheral periphlebitis - mild peripheral vascular sheathing
    • CMO in 50%
    • long term ERM common, cataract caused by inflammation or steroids, secondary glaucoma
  • maquarades
    • lymphoma
    • endophthalmosis
    • toxoplasmosis
    • investigate bloods - ESR, CRP, U&E, ACE
    • OCT - cystoid macular odema
    • OCT A - reduced blood flow
    • FA - peripheral shut down
    treatments
    • varies between centres
    • treat underlying causes
    • steroids - oral, intravitreal - ozurdex, iluvien
    • second line immunosupression - mycofenolate, mofetil, tarcolimus
    • cataract and glaucoma management
    can have peri ocular steroid injection, non steroidal anti inflammatory, peripheral cyrotherapy, retinal laser if siginificant shut down, vitrectomy
  • posterior uveitis
    • loss of vision
    • painless
    • floaters
    • photopsia
    • blurring
    • mild vitritis
    • posterior pole lesions
    • ill defined patches - creamy, white, grey, depending on cause
    • peripheral vasculature shut down
    • neovascular changes
    • CNV
  • choroiditis
    • inflammation of choroid
    • inflammatory foci at level of choroid and RPE
    • isolated choroiditis is rare
  • retintis
    • inflammation of retina
    • conjunction with choroiditis and vasculitis
    • demarcated areas of infection
    • leave pigmented atrophy when no longer active
    • haemorrhage and exudates often apparent
  • vasculitis
    • inflammation of retinal vasculature
    • unusual in isolation
    • peri vascular sheathing
    • exudates
    • cotton wool spots
    • occlusion
    • neovascular changes
  • neuroretinitis
    • inflammation of optic nerve
    • peripapillary area and neural retina
    • lipid rich exudate may form macular star
    • can be clinically similar to hypertensive retinopathy
  • referral for posterior uveitis
    • urgent
    • contact local centre
    • often local guidelines for time frames to be seen
    • needs specialist input
    • empirical investigation and treatment started on first visit
  • causes of posterior uveitis
    • wide range
    • infectious
    • autoimune
    • secondary
  • infectious causes - parasitic
    • toxoplasmosis - may be symptomatic , can be congenital from mother or aquired from soil, cat faces, undercooked meat
    • toxocara
  • infectious causes - viral
    • acute retinal necrosis - herpes simplex and zoster
    • CMV retinitis - immunocompromised px
    • progressive retinal necrosis - PORN , herpes zoster
  • other causes
    • fungal candida - endogenous
    • presumed ocular histoplasmosis syndrome POHS as seen in HIV
    • bacterial - TB, syphilis, lyme
  • autoimmune causes
    • multiple sclerosis
    • sarcodosis
    • VKH
    • bechets
    • miscallaneous idiopathic chorioretinopathies
    • sympathetic opthalmia
  • multiple sclerosis
    • neuroinflammatory condition causing unmylination of neurones
    • most common ocular association is optic neuritis
    • can be associated with IU and play plantis
    • MRI brain scan part of screening
  • sarcoidosis
    • autoimmune systemic condition
    • collections of anti inflammatory cells produce granulomas
    • can exist throughout body
    • ocular complications include granulomatous anterior uveitis
    • Intermediate and posterior uveitis
    • chest x ray shows hilar lymphadenopathy
    • blood shows raised serum ACE
  • VKH
    • vogt Koyangi Harada syndrome
    • multisystem autoimmune disease of melanocyte containing tissues
    • prodromal phases include neurological manifestations
    • acute uvietic stage includes dalen fuchs nodules, panuveitis leading to exudative detachment
  • bechets disease
    • idiopathic multisystem disease
    • recurrent mouth ulcers, genital ulceration and uveitis
    • vasculitis always present – involves small medium and large veins and arteries
    • Central nervous system and cardiovascular complications are common and mortality is 5% at 5 years
    • Disease common in patients from countries along the silk route
    • Inflammation throughout the entire uveal tract
  • white dot syndromes
    one subgroup
    • MEWDS - multiple evanescent white dot syndrome
    • AIBSE - acute idiopathic blind spot enlargement
    • APMPEE - acute posterior multifocal placoid pigment
    • serpigenious
    • acute macular neuroretinopathy
    • AZOOR - acute zonal occult outer retinopathy
    • PIC - punctuate inner retinopathy
    • MFCPU - multifocal choroiditis and pan uveitis
    • SFU - progressive sub retinal fibrosis and uveitis
    • includes bird shot retinopathy
    • others are rare
  • MEWDS= multiple evanescent white dot syndrome
    • chorioretinopathy
  • AMPEE - acute posterior multifocal placoid pigment epitheliopathy
    • chorioretinopathy
  • serpingenous
    • chorioreitnopathies
  • AZOOR - acute zonal occult outer retinopathy
    • chorioretinopathy
  • PIC - punctuate inner chorioretinopathy
    • see image
  • SFU - progressive sub retinal fibrosis and uveitis
    • see image
  • MFU - multifocal choroiditis
    see image
  • bird shot chorioretinopathy
    • see image
  • secondary causes
    • latrogenic - due to medication such as chemotherapy
    • masquarade - lymphoma
    • paraneoplastic syndromes - cancer associated retinopathy, bilateral diffuse uveal melanocytotic proliferation BDUMP, melanoma associated retinopathy
  • investigations into secondary causes
    • bloods
    • systemic x ray, CT, MRI brain
    • OCT
    • OCTA
    • ICG
    • FFA
  • treatment
    • treat any underlying cause - anti biotics, anti MS meds, antivirals, anti fungals
    • steroids - need admission for high dosage to initiate treatment - exclude infection
    • ozurdex , illuvien
    • Anti VEGF for CNV
    • second line treatment - mycophenolate, methotrexate, tacrolimus
    • adulimumab, rituximab
  • prognosis
    • extremely variable based on cause
    • if macula not involved then good prognosis
  • summary
    • SUN and ISUG classify according to location, aetiology, timing of clinical activity
    • causes are infective, non infective or autoimmune, secondary or masqurade
    • treatment includes treating underlying cause, immunosuppression, steroids local or systemic, second line immunotherapy, biologic therapy
    • prognosis variable depending on cause and area
    • wide range of spectrum of disease presentation and activity
    • early referal as significant risk of irreversible sight loss
    • treatment in specialist centre needed